Rigel Pharmaceutical Inc. buy Citigroup Inc.
Start price
06.03.25
/
50%
€0.74
Target price
06.03.26
€50.83
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 06.03.26. The prediction end date can be changed by Citigroup_Inc_ at any time.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Rigel Pharmaceutical Inc. | - | - |
| iShares Core DAX® | 0.734% | 1.458% |
| iShares Nasdaq 100 | -2.686% | -0.146% |
| iShares Nikkei 225® | -2.261% | -2.729% |
| iShares S&P 500 | -1.346% | 0.467% |
Comments by Citigroup_Inc_ for this prediction
In the thread Rigel Pharmaceutical Inc. diskutieren
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) had its price target raised by analysts at Citigroup Inc. from $49.00 to $55.00. They now have a "buy" rating on the stock.
Ratings data for RIGL provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Rigel Pharmaceutical Inc.
Rigel Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€0.74
12.11.24
12.11.24
€46.15
12.11.25
12.11.25
-
13.11.25
13.11.25
Rigel Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€1.40
07.03.24
07.03.24
€3.67
07.03.25
07.03.25
-47.24%
08.03.25
08.03.25